BRAI, ANNALAURA
 Distribuzione geografica
Continente #
EU - Europa 2.412
NA - Nord America 2.352
AS - Asia 1.474
SA - Sud America 324
AF - Africa 93
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.662
Nazione #
US - Stati Uniti d'America 2.275
RU - Federazione Russa 714
IT - Italia 471
SG - Singapore 461
CN - Cina 394
GB - Regno Unito 356
BR - Brasile 279
IE - Irlanda 261
VN - Vietnam 203
DE - Germania 126
HK - Hong Kong 110
SE - Svezia 102
FR - Francia 100
KR - Corea 92
IN - India 73
UA - Ucraina 55
FI - Finlandia 46
ZA - Sudafrica 44
NL - Olanda 42
CA - Canada 36
ES - Italia 32
MX - Messico 30
BD - Bangladesh 26
TR - Turchia 20
BE - Belgio 18
JP - Giappone 18
CZ - Repubblica Ceca 17
PL - Polonia 17
AR - Argentina 12
IQ - Iraq 11
KE - Kenya 11
AT - Austria 9
EC - Ecuador 9
IR - Iran 9
PK - Pakistan 9
CO - Colombia 8
NG - Nigeria 7
AE - Emirati Arabi Uniti 6
HR - Croazia 6
ID - Indonesia 6
PH - Filippine 6
PT - Portogallo 6
TN - Tunisia 6
UZ - Uzbekistan 6
VE - Venezuela 6
AU - Australia 5
CI - Costa d'Avorio 5
GR - Grecia 5
LI - Liechtenstein 5
MA - Marocco 5
RO - Romania 5
DZ - Algeria 4
SA - Arabia Saudita 4
DK - Danimarca 3
EG - Egitto 3
ET - Etiopia 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
KZ - Kazakistan 3
LV - Lettonia 3
OM - Oman 3
UY - Uruguay 3
BG - Bulgaria 2
CH - Svizzera 2
CL - Cile 2
DO - Repubblica Dominicana 2
EE - Estonia 2
LT - Lituania 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
RS - Serbia 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
EU - Europa 1
GA - Gabon 1
GY - Guiana 1
HU - Ungheria 1
IL - Israele 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
SN - Senegal 1
TH - Thailandia 1
UG - Uganda 1
Totale 6.662
Città #
Singapore 268
Dallas 267
Southend 267
Dublin 256
Moscow 221
Ashburn 201
Siena 162
San Jose 155
Fairfield 146
Santa Clara 142
Chandler 118
Hefei 108
Hong Kong 106
Beijing 104
Seoul 88
New York 72
Ho Chi Minh City 69
Los Angeles 60
Milan 59
Wilmington 59
Council Bluffs 57
Houston 55
Woodbridge 55
Seattle 54
Jacksonville 52
The Dalles 48
Ann Arbor 47
Cambridge 45
Lauterbourg 42
Munich 40
Johannesburg 39
Menlo Park 37
Princeton 34
Dong Ket 33
Florence 33
São Paulo 33
Bengaluru 32
Hanoi 28
Chicago 25
Buffalo 22
Shanghai 21
Boardman 20
Frankfurt am Main 17
Düsseldorf 16
Lappeenranta 16
Nuremberg 16
Amsterdam 15
Poplar 15
Helsinki 14
London 14
Orem 14
Rome 14
Tokyo 14
Warsaw 14
Brussels 13
Columbus 13
Haiphong 13
Nanjing 13
Portsmouth 13
Brno 11
Chennai 11
San Mateo 11
Brasília 10
Brooklyn 10
Guangzhou 10
Toronto 10
Dearborn 9
Turku 9
Belo Horizonte 8
Mexico City 8
Montreal 8
Málaga 8
Phoenix 8
Rio de Janeiro 8
Brescia 7
Calci 7
Da Nang 7
Denver 7
Fremont 7
Guayaquil 7
Hillsboro 7
Hải Dương 7
Redondo Beach 7
Santo André 7
Stockholm 7
Abuja 6
Ankara 6
Indianapolis 6
Izmir 6
Manchester 6
Querétaro 6
Redwood City 6
Salt Lake City 6
San Diego 6
Zagreb 6
Barnet 5
Boston 5
Ghent 5
Harderwijk 5
Mumbai 5
Totale 4.325
Nome #
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents 314
DDX3X inhibitors, an effective way to overcome HIV-1 resistance 291
A novel bioresponsive self-immolative spacer based on aza-quinone methide reactivity for the controlled release of thiols, phenols, amines, sulfonamides or amides 290
DDX3X Helicase Inhibitors as a New Strategy to Fight the West Nile Virus Infection 282
Development and in Vitro Evaluation of a Microbicide Gel Formulation for a Novel Non-Nucleoside Reverse Transcriptase Inhibitor Belonging to the N-Dihydroalkyloxybenzyloxopyrimidines (N-DABOs) Family 278
Homology Model-Based Virtual Screening for the Identification of Human Helicase DDX3 Inhibitors 269
Synthesis and Antiviral Activity of Novel 1,3,4-Thiadiazole Inhibitors of DDX3X 251
An alternative synthetic approach for the synthesis of biologically relevant 1,4-disubstituted pyrazolo[3,4-d]pyrimidines 235
Rhodanine derivatives as potent anti-HIV and anti-HSV microbicides 225
Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules 216
Exploring the implication of DDX3X in DENV infection: discovery of the first-in-class DDX3X fluorescent inhibitor 213
Protein-protein interactions and human cellular cofactors as new targets for HIV therapy 212
Si113-prodrugs selectively activated by plasmin against hepatocellular and ovarian carcinoma 198
Unique domain for a unique target: selective inhibitors of host cell DDX3X to fight emerging viruses 179
A greener technique for microwave-assisted O-Silylation and silyl ether deprotection of uridine and other substrates 174
DEAD-Box Helicase DDX3X as a host target against emerging viruses: new insights for medicinal chemical approaches 169
Viral Envelope Membrane: A Special Entry Pathway and a Promising Drug Target 167
Efficient use of agricultural waste to naturally fortify Tenebrio molitor mealworms and evaluation of their nutraceutical properties 164
Novel broad spectrum virucidal molecules against enveloped viruses 164
Development and validation of derivatization-based LC-MS/MS method for quantification of short-chain fatty acids in human, rat, and mouse plasma 162
Tenebrio molitor as a Simple and Cheap Preclinical Pharmacokinetic and Toxicity Model 158
Proteomic analysis identifies the RNA helicase DDX3X as a host target against SARS-CoV-2 infection 148
Exploiting fall foliage by-products to optimize Tenebrio molitor nutraceutical value 147
Progress towards adjuvant development: focus on antiviral therapy 147
Biological Evaluation and In Vitro Characterization of ADME Profile of In-House Pyrazolo[3,4-d]pyrimidines as Dual Tyrosine Kinase Inhibitors Active against Glioblastoma Multiforme 146
Reversible monoacylglycerol lipase inhibitors: discovery of a new class of benzylpiperidine derivatives 144
The replacement of flour-based feed with pellets reduces dustiness and improves tenebrio molitor breeders' safety 129
Sweet cherry extract as permeation enhancer of tyrosine kinase inhibitors: a promising prospective for future oral anticancer therapies 126
Proteins from Tenebrio molitor: an interesting functional ingredient and a source of ACE inhibitory peptides 126
Identification of Novel Non-Nucleoside Inhibitors of Zika Virus NS5 Protein Targeting MTase Activity 122
Use of distillery by-products as Tenebrio molitor mealworm feed supplement 121
Design, synthesis, ADME and biological evaluation of benzylpiperidine and benzylpiperazine derivatives as novel reversible monoacylglycerol lipase (MAGL) inhibitors 120
Upcycling Milk Industry Byproducts into Tenebrio molitor Larvae: Investigation on Fat, Protein, and Sugar Composition 114
Infesting Seaweeds as a Novel Functional Food: Analysis of Nutrients, Antioxidants and ACE Inhibitory Effects 103
Targeting ddx3x helicase activity with ba103 shows promising therapeutic effects in preclinical glioblastoma models 102
Exploitation of the Nutraceutical Potential of the Infesting Seaweed Chaetomorpha linum as a Yellow Mealworms’ Feed: Focus on Nutrients and Antioxidant Activity 94
An Innovation 10 Years in the Making: The Stories in the Pages of ACS Medicinal Chemistry Letters 88
DDX3 inhibitors show antiviral activity against positive-sense single-stranded RNA viruses but not against negative-sense single-stranded RNA viruses: The coxsackie B model 87
In This Issue, Volume 12, Issue 7 56
Investigating the potential of the SI306 Src inhibitor and its liposomal formulation in the non-small cell lung cancer treatment 46
Insects as Source of Nutraceuticals with Antioxidant, Antihypertensive, and Antidiabetic Properties: Focus on the Species Approved in Europe up to 2024 33
Functionalization of Tenebrio molitor with Olive Mill Wastewater: Growth, Antioxidant Activity, and Metabolomic Insights 16
From Ecological Threat to Bioactive Resource: The Nutraceutical Components of Blue Crab (Callinectes sapidus) 5
Totale 6.831
Categoria #
all - tutte 19.740
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.740


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021150 0 0 0 0 0 0 0 0 0 70 28 52
2021/2022324 9 27 32 15 17 23 15 15 32 37 39 63
2022/2023395 22 56 41 51 43 59 24 37 31 15 7 9
2023/2024544 18 11 21 34 10 127 159 16 3 21 35 89
2024/20251.454 51 34 152 111 168 82 104 108 118 60 126 340
2025/20263.019 246 404 296 439 710 119 360 112 119 214 0 0
Totale 6.831